Literature DB >> 26275954

Effects of BRCA1/2 on Ovarian and Breast Cancer Survival--Response.

Qian Zhong1, Hong-Ling Peng1, Xia Zhao1, Lin Zhang2, Wei-Ting Hwang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26275954      PMCID： PMC4538982          DOI： 10.1158/1078-0432.CCR-15-0931

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

Authors:  M K Parmar; V Torri; L Stewart
Journal:  Stat Med       Date:  1998-12-30       Impact factor: 2.373

2.  Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.

Authors:  J Boyd; Y Sonoda; M G Federici; F Bogomolniy; E Rhei; D L Maresco; P E Saigo; L A Almadrones; R R Barakat; C L Brown; D S Chi; J P Curtin; E A Poynor; W J Hoskins
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

3.  Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.

Authors:  Qian Zhong; Hong-Ling Peng; Xia Zhao; Lin Zhang; Wei-Ting Hwang
Journal:  Clin Cancer Res       Date:  2014-10-27       Impact factor: 12.531

4.  Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.

Authors:  John R McLaughlin; Barry Rosen; Joel Moody; Tuya Pal; Isabel Fan; Patricia A Shaw; Harvey A Risch; Thomas A Sellers; Ping Sun; Steven A Narod
Journal:  J Natl Cancer Inst       Date:  2012-12-20       Impact factor: 13.506
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.